Colinz Laboratories Ltd has announced significant corporate developments following a board meeting held on November 27, 2025. The company has made two key decisions that could impact its operations and governance structure.

Authorization for Factory Premises Sale

The board of directors has granted authority to Mr. Narayan Kutty Menon, Whole-time Director and CEO, to identify potential buyers and negotiate terms for the proposed sale of the company's factory premises. This decision follows shareholder approval obtained through a postal ballot on November 17, 2025, under Section 180(1)(a) of the Companies Act, 2013.

New Company Secretary Appointment

In addition to the sale authorization, the board has approved the appointment of Ms. Falguni Kumawat as the new Company Secretary and Compliance Officer. This appointment will take effect from December 1, 2025.

Here's a summary of the key details:

The board meeting, which commenced at 3:30 p.m., concluded at 5:30 p.m.

These developments suggest that Colinz Laboratories is taking strategic steps towards potential restructuring with the proposed factory sale, while also strengthening its corporate governance with the appointment of an experienced Company Secretary.

Colinz Laboratories Limited recently concluded a significant postal ballot process, resulting in the approval of two special resolutions by its shareholders. The e-voting, which took place from October 15 to November 14, 2025, focused on the company's plans to sell, lease, mortgage, or dispose of key properties.

Resolutions Passed

The shareholders voted on two important resolutions:

1. The sale, lease, mortgage, or disposal of the company's factory located in Sinnar, Nashik.
2. Similar actions for the company's office in Mumbai.

Voting Results

The outcome of the postal ballot demonstrated strong shareholder support for both resolutions:

The overwhelming majority in favor of these resolutions indicates significant shareholder alignment with the company's strategic decisions regarding its property assets.

Implications

The approval of these resolutions grants Colinz Laboratories the flexibility to make strategic decisions regarding its properties in Nashik and Mumbai. This could potentially impact the company's operational footprint and financial structure, depending on how the management chooses to proceed with these newly approved options.

Shareholders and market observers may want to keep an eye on future announcements from Colinz Laboratories regarding the execution of these approved actions and their potential impact on the company's operations and financial position.

As the company moves forward with these approvals, it may lead to changes in its asset structure, potentially affecting its balance sheet and operational capabilities. However, the specific plans and timeline for implementing these resolutions have not been disclosed in the current announcement.